Go Pro

MarketBeat Instant News Alerts

Weave Communications logo with Healthcare background

B. Riley Financial Initiates Coverage on Weave Communications (NYSE:WEAV)

B. Riley Financial started coverage on Weave Communications in a research report on Tuesday. They set a "buy" rating and a $8.25 price objective for the company.

NYSE:WEAV
Read B. Riley Financial Initiates Coverage on Weave Communications (NYSE:WEAV)

Wolfe Research Begins Coverage on First Tracks Biotherapeutics (NASDAQ:TRAX)

Wolfe Research began coverage on shares of First Tracks Biotherapeutics in a research report on Tuesday. They set an "outperform" rating and a $83.00 price objective for the company.

NASDAQ:TRAX
Read Wolfe Research Begins Coverage on First Tracks Biotherapeutics (NASDAQ:TRAX)
Globalstar logo with Communication Services background

Globalstar (NASDAQ:GSAT) Downgraded to "Hold" Rating by Craig Hallum

Craig Hallum downgraded shares of Globalstar from a "buy" rating to a "hold" rating and set a $90.00 price target on the stock. in a research report on Tuesday.

NASDAQ:GSAT
Read Globalstar (NASDAQ:GSAT) Downgraded to "Hold" Rating by Craig Hallum
Eyepoint Pharmaceuticals logo with Healthcare background

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by Chardan Capital to Neutral

Chardan Capital cut Eyepoint Pharmaceuticals from a "buy" rating to a "neutral" rating and set a $5.00 price objective for the company. in a research report on Tuesday.

NASDAQ:EYPT
Read Eyepoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by Chardan Capital to Neutral
Autohome logo with Communication Services background

Autohome (NYSE:ATHM) Downgraded to "Underperform" Rating by Bank of America

Bank of America cut Autohome from a "neutral" rating to an "underperform" rating and set a $19.00 price target on the stock. in a research note on Tuesday.

NYSE:ATHM
Read Autohome (NYSE:ATHM) Downgraded to "Underperform" Rating by Bank of America
Strawberry Fields REIT logo with Real Estate background

Compass Point Upgrades Strawberry Fields REIT (NYSEAMERICAN:STRW) to Buy

Compass Point raised Strawberry Fields REIT from a "neutral" rating to a "buy" rating in a research report on Tuesday.

NYSEAMERICAN:STRW
Read Compass Point Upgrades Strawberry Fields REIT (NYSEAMERICAN:STRW) to Buy

Trending News

All MarketBeat Instant News Alerts

Ramaco Resources logo with Materials background

Morgan Stanley Has Lowered Expectations for Ramaco Resources (NASDAQ:METC) Stock Price

NASDAQ:METC
Read Morgan Stanley Has Lowered Expectations for Ramaco Resources (NASDAQ:METC) Stock Price
BHP Group logo with Materials background

BHP Group H2 Earnings Call Highlights

NYSE:BHP
Read BHP Group H2 Earnings Call Highlights
TH International logo with Consumer Discretionary background

TH International Q2 Earnings Call Highlights

NASDAQ:THCH
Read TH International Q2 Earnings Call Highlights
ReNew Energy Global logo with Utilities background

ReNew Energy Global Q1 Earnings Call Highlights

NASDAQ:RNW
Read ReNew Energy Global Q1 Earnings Call Highlights
iQIYI logo with Communication Services background

iQIYI Q2 Earnings Call Highlights

NASDAQ:IQ
Read iQIYI Q2 Earnings Call Highlights
Elauwit Connection logo with Communication Services background

Elauwit Connection Q2 Earnings Call Highlights

NASDAQ:ELWT
Read Elauwit Connection Q2 Earnings Call Highlights
Honeywell International logo with Industrials background

Royal Bank Of Canada Issues Pessimistic Forecast for Honeywell International (NASDAQ:HON) Stock Price

NASDAQ:HON
Read Royal Bank Of Canada Issues Pessimistic Forecast for Honeywell International (NASDAQ:HON) Stock Price
Huntington Bancshares logo with Finance background

Huntington Bancshares' (HBAN) "Outperform" Rating Reiterated at Royal Bank Of Canada

NASDAQ:HBAN
Read Huntington Bancshares' (HBAN) "Outperform" Rating Reiterated at Royal Bank Of Canada
Enliven Therapeutics logo with Healthcare background

Enliven Therapeutics (NASDAQ:ELVN) Now Covered by Analysts at William Blair

NASDAQ:ELVN
Read Enliven Therapeutics (NASDAQ:ELVN) Now Covered by Analysts at William Blair
Editas Medicine logo with Healthcare background

Editas Medicine (NASDAQ:EDIT) Coverage Initiated at LADENBURG THALM/SH SH

NASDAQ:EDIT
Read Editas Medicine (NASDAQ:EDIT) Coverage Initiated at LADENBURG THALM/SH SH
argenex logo with Healthcare background

Royal Bank Of Canada Boosts argenex (NASDAQ:ARGX) Price Target to $1,100.00

NASDAQ:ARGX
Read Royal Bank Of Canada Boosts argenex (NASDAQ:ARGX) Price Target to $1,100.00
Centrus Energy logo with Energy background

Centrus Energy (NYSE:LEU) Coverage Initiated at Barclays

NYSE:LEU
Read Centrus Energy (NYSE:LEU) Coverage Initiated at Barclays
Gartner logo with Industrials background

BMO Capital Markets Lowers Gartner (NYSE:IT) Price Target to $206.00

NYSE:IT
Read BMO Capital Markets Lowers Gartner (NYSE:IT) Price Target to $206.00
Corporacion America Airports logo with Industrials background

Corporacion America Airports (NYSE:CAAP) Posts Earnings Results, Misses Expectations By $0.18 EPS

NYSE:CAAP
Read Corporacion America Airports (NYSE:CAAP) Posts Earnings Results, Misses Expectations By $0.18 EPS
Willdan Group logo with Industrials background

Willdan Group (NASDAQ:WLDN) Receives "Outperform" Rating from Wedbush

NASDAQ:WLDN
Read Willdan Group (NASDAQ:WLDN) Receives "Outperform" Rating from Wedbush
Enliven Therapeutics logo with Healthcare background

Enliven Therapeutics (NASDAQ:ELVN) Now Covered by Barclays

NASDAQ:ELVN
Read Enliven Therapeutics (NASDAQ:ELVN) Now Covered by Barclays
Eyepoint Pharmaceuticals logo with Healthcare background

Eyepoint Pharmaceuticals' (EYPT) Sector Perform Rating Reiterated at Royal Bank Of Canada

NASDAQ:EYPT
Read Eyepoint Pharmaceuticals' (EYPT) Sector Perform Rating Reiterated at Royal Bank Of Canada

Sinda (NYSE:SIND) Now Covered by Canaccord Genuity Group

NYSE:SIND
Read Sinda (NYSE:SIND) Now Covered by Canaccord Genuity Group
Walker & Dunlop logo with Finance background

Citizens Jmp Lowers Walker & Dunlop (NYSE:WD) Price Target to $55.00

NYSE:WD
Read Citizens Jmp Lowers Walker & Dunlop (NYSE:WD) Price Target to $55.00
Docusign logo with Technology background

Docusign's (DOCU) Market Outperform Rating Reaffirmed at Citizens Jmp

NASDAQ:DOCU
Read Docusign's (DOCU) Market Outperform Rating Reaffirmed at Citizens Jmp
TuHURA Biosciences logo with Healthcare background

TuHURA Biosciences' (HURA) "Market Outperform" Rating Reaffirmed at Citizens Jmp

NASDAQ:HURA
Read TuHURA Biosciences' (HURA) "Market Outperform" Rating Reaffirmed at Citizens Jmp
Duolingo logo with Consumer Discretionary background

Duolingo (NASDAQ:DUOL) Upgraded to Buy at DA Davidson

NASDAQ:DUOL
Read Duolingo (NASDAQ:DUOL) Upgraded to Buy at DA Davidson
Nuvation Bio logo with Healthcare background

Nuvation Bio (NYSE:NUVB) Coverage Initiated by Analysts at JPMorgan Chase & Co.

NYSE:NUVB
Read Nuvation Bio (NYSE:NUVB) Coverage Initiated by Analysts at JPMorgan Chase & Co.
LGN logo with Industrials background

LGN (NASDAQ:LGN) Given "Buy" Rating at Guggenheim

NASDAQ:LGN
Read LGN (NASDAQ:LGN) Given "Buy" Rating at Guggenheim

Featured Articles and Offers

Alert Categories

All Alerts